Search results for "Endocrine orbitopathy"

showing 4 items of 4 documents

Quality of Life and Occupational Disability in Endocrine Orbitopathy

2009

SUMMARY Background: In endocrine orbitopathy (EO), disfiguring proptosis and diplopia impair patients' quality of life both at home and at work. Methods: From late 2006 to the beginning of 2008, 250 outpatients in an interdisciplinary thyroid and eye clinic filled out a questionnaire about their quality of life, occupational disability, and use of psychotherapy. 400 physicians who referred their EO patients to the clinic also participated in a survey on these issues. Results: 45% of the patients complained of restrictions in their daily activities, and 38% reported impaired selfperception. 36% were on sick leave because of EO. 28% were disabled, 5% had retired early, and 3% had lost their j…

AdultEmploymentMalemedicine.medical_specialtyActivities of daily livingAdolescentmedicine.medical_treatmentRisk AssessmentDisability EvaluationYoung AdultQuality of life (healthcare)Risk FactorsGermanySurveys and QuestionnairesmedicineHumansYoung adultAgedAged 80 and overDiplopiaRehabilitationbusiness.industryIncidenceIncidence (epidemiology)Endocrine orbitopathyGeneral MedicineMiddle AgedGraves OphthalmopathyPsychotherapyTreatment OutcomeSick leaveQuality of LifePhysical therapyOriginal ArticleFemalemedicine.symptombusinessDeutsches Ärzteblatt international
researchProduct

Ciamexone in endocrine orbitopathy. A randomized double-blind, placebo-controlled study.

1990

Abstract The influence of ciamexone on the activity and course of endocrine orbitopathy was investigated. Fifty-one patients with active orbitopathy classes II-VI were allocated randomly to two groups: over a period of six months, 26 patients received 300 mg/day ciamexone and 25 patients received placebo tablets. In both groups, prednisolone was administered in addition in the first four weeks. Ophthalmological investigations and clinical tests as well as orbit sonography were carried out before as well as one, three and six months after the beginning of therapy. Before and after treatment, computer tomography of the orbit was performed. Symptoms and signs did not show any significant impro…

AdultMalemedicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and Metabolismmedicine.medical_treatmentEye diseasePrednisoloneAziridinesPlacebo-controlled studyVisual AcuityPlaceboRandom AllocationEndocrinologyAdjuvants ImmunologicDouble-Blind MethodInternal medicineOrbital DiseasesMedicineHumansExophthalmusIntraocular PressureAgedChemotherapybiologybusiness.industryThyroiditis AutoimmuneEndocrine orbitopathyGeneral MedicineMiddle Agedbiology.organism_classificationmedicine.diseaseEndocrinologyPrednisoloneCorticosteroidFemalebusinessmedicine.drugActa endocrinologica
researchProduct

Aktuelle interdisziplinäre Diagnostik und Therapie der endokrinen Orbitopathie*

2008

business.industryMedicineEndocrine orbitopathyGeneral MedicinebusinessBioinformaticsDMW - Deutsche Medizinische Wochenschrift
researchProduct

Nonsteroid Immunosuppressants in Endocrine Orbitopathy

2009

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismAziridinesEndocrine orbitopathyGeneral MedicineDermatologyGraves DiseaseEndocrinologyAzathioprineCyclosporineInternal MedicinemedicineHumansbusinessCyclophosphamideImmunosuppressive AgentsExperimental and Clinical Endocrinology & Diabetes
researchProduct